Cambrex contests fines for violations
Pharmaceutical company Cambrex Corp. has contested state fines for alleged safety violations for a fire and explosion at its plant in Charles City last fall.
It has been reported that Merck Sharp & Dohme, a unit of Merck & Co, will be pledging guilty to one count of misbranding Vioxx with a penalty of $321.6 million criminal fine as well as $628.3 million in order to settle civil claims regarding the sale of Vioxx for unapproved uses along with fake statements about its cardiovascular safety.